TGF-beta inhibitors (National Research Center Of Canada)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTGF-beta inhibitors (National Research Center Of Canada)
Drug Alias NameL-11817
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTransforming growth factor beta receptors antagonists
TargetsTransforming growth factor beta receptors
Therapy Area/IndicationsCardiovascular DiseasesKidney DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsCardiovascular DiseasesKidney DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A